Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations

被引：65

作者：

Nudelman, Igor

Rebibo-Sabbah, Annie

Shallom-Shezifi, Dalia

Hainrichson, Mariana

Stahl, Ido

Ben-Yosef, Tamar ^{[1
]}

Baasov, Timor

机构：

[1] Technion Israel Inst Technol, Dept Genet, Fac Med, IL-31096 Haifa, Israel

[2] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel

[3] Technion Israel Inst Technol, Edith & Joseph Fischer enzyme Inhibitors Lab, Dept Chem, Inst Catalysis Sci & Technol, IL-32000 Haifa, Israel

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 24期

基金：

以色列科学基金会;

关键词：

aminoglycosides; cystic fibrosis; drug design; stop mutation suppression; Usher syndrome;

D O I：

10.1016/j.bmcl.2006.09.013

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of new derivatives of the clinically used aminoglycoside antibiotic paromomycin were designed, synthesized, and their ability to read-through premature stop codon mutations was examined in both in vitro translation system and ex vivo mammalian cultured cells. One of these structures, a pseudo-trisaccharide derivative, showed notably higher stop codon read-through activity in cultured cells compared to those of paromomycin and gentamicin. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：6310 / 6315

页数：6

共 50 条

[31] EFFECT OF READTHROUGH TREATMENT ON FIBROBLASTS OF PATIENTS AFFECTED WITH LYSOSOMAL DISEASES CAUSED BY PREMATURE TERMINATION CODONS
Matalonga, L.
Gort, L.
Ribes, A.
JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S103 - S103
[32] Advances in human mitochondrial diseases - Molecular genetic analysis of pathogenic mtDNA mutations
Davidson, E
King, MP
TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (01) : 16 - 24
[33] Expanding the Phenotypic and Genetic Spectrum of Neuromuscular Diseases Caused by DYNC1H1 Mutations
Li, Jia-Tong
Dong, Si-Qi
Zhu, Dong-Qing
Yang, Wen-Bo
Qian, Ting
Liu, Xiao-Ni
Chen, Xiang-Jun
FRONTIERS IN NEUROLOGY, 2022, 13
[34] Human Genetic Disorders Caused by Mutations in Genes Encoding Biosynthetic Enzymes for Sulfated Glycosaminoglycans
Mizumoto, Shuji
Ikegawa, Shiro
Sugahara, Kazuyuki
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (16) : 10953 - 10961
[35] In vivo assessment of photoreceptor function in human diseases caused by photoreceptor-specific gene mutations
Cideciyan, AV
VERTEBRATE PHOTOTRANSDUCTION AND THE VISUAL CYCLE, PT B, 2000, 316 : 611 - 626
[36] Clinical and genetic analyses of premature mitochondrial encephalopathy with epilepsia partialis continua caused by novel biallelic NARS2 mutations
Hu, Wenjing
Fang, Hongjun
Peng, Yu
Li, Li
Guo, Danni
Tang, Jingwen
Yi, Jurong
Liu, Qingqing
Qin, Wei
Wu, Liwen
Ning, Zeshu
FRONTIERS IN NEUROSCIENCE, 2022, 16
[37] Designer Aminoglycosides That Selectively Inhibit Cytoplasmic Rather than Mitochondrial Ribosomes Show Decreased Ototoxicity A STRATEGY FOR THE TREATMENT OF GENETIC DISEASES
Shulman, Eli
Belakhov, Valery
Wei, Gao
Kendall, Ann
Meyron-Holtz, Esther G.
Ben-Shachar, Dorit
Schacht, Jochen
Baasov, Timor
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (04) : 2318 - 2330
[38] Developmental defects caused by mutations in the p52 subunit of TFIIH in Drosophila mimic human diseases
Fregoso, Lomas
Laine, Jean-Philippe
Aguilar-Fuentes, Javier
Moquet, Vincent
Reynaud, Enrique
Coin, Frederic
Egly, J.
Zurita, Mario
DEVELOPMENTAL BIOLOGY, 2007, 306 (01) : 345 - 346
[39] Zebrafish: A Powerful Model for Understanding the Functional Relevance of Noncoding Region Mutations in Human Genetic Diseases
Mann, Anita
Bhatia, Shipra
BIOMEDICINES, 2019, 7 (03)
[40] 2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases
Bidou, Laure
Bugaud, Olivier
Merer, Goulven
Coupet, Matthieu
Hatin, Isabelle
Chirkin, Egor
Karri, Sabrina
Demais, Stephane
Francois, Pauline
Cintrat, Jean-Christophe
Namy, Olivier
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (35)

← 1 2 3 4 5 →